CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company’s Chief Development Officer ...
(Reuters) -Moderna said on Wednesday it would discontinue development of its experimental vaccine to prevent cytomegalovirus, a common cause of birth defects, after it failed to meet the main goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results